Indications for implantable cardiac defibrillators in patients with congestive heart failure: Implicatons of the sudden cardiac death in heart failure trial

被引：0
作者：
Pourati I. [1 ]
Hyder M. [1 ]
Rosenthal L. [1 ]
机构：
[1] Department of Medicine, The Division of Cardiovascular Medicine, UMass Memorial Medical Center, Worcester, MA 01655
来源：
Current Cardiology Reports | 2005年 / 7卷 / 3期
关键词：
Amiodarone; Ventricular Tachycardia; Implantable Defibrillator; Nonischemic Cardiomyopathy; Multicenter Automatic Defibrillator Implantation Trial;
D O I：
10.1007/s11886-005-0081-8
中图分类号：
学科分类号：
摘要：
Sudden cardiac death (SCD) is a significant cause of mortality in patients suffering from heart failure and left ventricular dysfunction. Implantable cardioverter defibrillators have been shown to effectively reduce the incidence of SCD in this population. Recent clinical trials have redefined the indications and patient profiles for their use: from secondary prevention to primary prevention of SCD. In this article, we review the clinical trials contributing to the current practice guidelines, which include device therapy. Copyright © 2005 by Current Science Inc.
引用
收藏
页码：223 / 228
页数：5
相关论文
共 24 条
[1]  
Zheng Z.J., Croft J.B., Giles W.H., Mensah G.A., Sudden cardiac death in the United States, 1989 to 1998, Circulation, 104, pp. 2158-2163, (2001)
[2]  
Hallstrom A.P., Ornato J.P., Weisfeldt M., Et al., Public-access defibrillation and survival after out-of-hospital cardiac arrest, N. Engl. J. Med., 351, pp. 637-646, (2004)
[3]  
Zipes D.P., Roberts D., Results of the international study of the implantable pacemaker cardioverter-defibrillator. A comparison of epicardial and endocardial lead systems. The Pacemaker-Cardioverter-Defibrillator Investigators, Circulation, 92, pp. 59-65, (1995)
[4]  
The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators: A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias, N. Engl. J. Med., 337, pp. 1621-1623, (1997)
[5]  
Connolly S.J., Gent M., Roberts R.S., Et al., Canadian Implantable Defibrillator Study (CIDS): A randomized trial of the implantable cardioverter defibrillator against amiodarone, Circulation, 101, pp. 1297-1302, (2000)
[6]  
Kuck K.H., Cappato R., Siebels J., Ruppel R., Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: The Cardiac Arrest Study Hamburg (CASH), Circulation, 102, pp. 748-754, (2000)
[7]  
Salukhe T.V., Dimopoulos K., Sutton R., Et al., Life-years gained from defibrillator implantation: Markedly nonlinear increase during 3 years of follow-up and its implications, Circulation, 109, pp. 1848-1853, (2004)
[8]  
Bokhari F., Newman D., Greene M., Et al., Long-term comparison of the implantable cardioverter defibrillator versus amiodarone: Eleven-year follow-up of a subset of patients in the Canadian Implantable Defibrillator Study (CIDS), Circulation, 110, pp. 112-116, (2004)
[9]  
Oseroff O., Retyk E., Bochoeyer A., Subanalyses of secondary prevention implantable cardioverter-defibrillator trials: Antiarrhythmics versus implantable defibrillators (AVID), Canadian Implantable Defibrillator Study (CIDS), and Cardiac Arrest Study Hamburg (CASH), Curr. Opin. Cardiol., 19, pp. 26-30, (2004)
[10]  
ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices: Summary article, Circulation, 106, (2002)
123